Safety of Omitting Axillary Surgery in Breast Cancer Patients With Isolated Chest Wall Recurrence
Oncological Safety of Omitting Axillary Surgery in Breast Cancer Patients With Isolated Chest Wall Recurrence After Mastectomy
1 other identifier
observational
300
1 country
1
Brief Summary
The axillary management of breast cancer patients with operable isolated chest wall recurrence after mastectomy is unclear. We aim to determine if axillary restaging surgery can be safely omitted with no increased recurrences in this group of patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 1989
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 1989
CompletedFirst Submitted
Initial submission to the registry
October 12, 2023
CompletedFirst Posted
Study publicly available on registry
October 18, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedOctober 18, 2023
October 1, 2023
36 years
October 12, 2023
October 12, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
recurrence
axillary or distant recuurences
from date of surgery to date of recurrence, up to 5 years
Study Arms (2)
axillary surgery group
this group of patients had axillary surgery for axilla staging
no axillary surgery group
this group of patients had no axillary surgery for axilla staging
Interventions
Eligibility Criteria
female patients with breast cancer with mastectomy and has isolated chest wall recurrences.
You may not qualify if:
- Patients with evidence of concomitant distant or/and regional recurrences
- Patients who did not have surgery for their isolated chest wall recurrences.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
KK Women's and Children's Hospital
Singapore, Singapore
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 12, 2023
First Posted
October 18, 2023
Study Start
January 1, 1989
Primary Completion
December 31, 2024
Study Completion
December 31, 2024
Last Updated
October 18, 2023
Record last verified: 2023-10